You searched for "occlusion"
It’s not all about ARED - Time for a pragmatic approach to nutrition for eye health?
Advances in treatment for retinal diseases involving neovascularisation have undoubtedly changed the future of eye care across the UK for the better, but also created great challenges for service delivery in ophthalmology, particularly within the NHS. Some statistics are starting...Uveal melanoma
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...Hoya Vision Care announces winner of its first-ever international MiYOSMART Case Study Contest
The International MiYOSMART Case Study Contest was held at the 60th International Myopia Conference (IMC) 2024 meeting in Sanya, China, HOYA Vision Care launched its first-ever MiYOSMART Case Study Contest at the prestigious IMC meeting in Sanya, China, which plays...In conversation with Andrena McElvanney (President, MCLOSA)
We spoke to Andrena about MCLOSA's annual meeting this November, key developments in cornea and external eye disease, and plans for the association’s 30th anniversary. Andrena McElvanney (top, second from right) and the OSI council members. The Medical Contact Lens...Amnion-assisted conjunctival epithelial redirection (ACER): Enhancing stem cell transplantation treatment of total limbal stem cell deficiency
An exploration of Professor Harminder Dua’s recent work using a technique called amnion-assisted conjunctival epithelial redirection (ACER) to aid the success of conjunctival-limbal grafting procedures. ACER provides a refined way to use amniotic membrane (amnion), such as Omnigen® (NuVision® Biotherapies,...England Women’s Blind Football Captain credits Royal Blind School for helping her score an MBE in the King’s Birthday Honours
Samantha Gough, an inspirational visually impaired athlete from Edinburgh, has been awarded an MBE in the 2026 King’s Birthday Honours for services to sport and to the visually impaired community. Sam’s journey to becoming one of Britain’s most accomplished visually...Conference report: SORD: Student Ophthalmology Review Day 2024
The Student Ophthalmology Review Day (SORD), now in its fifth year, was hosted at the Royal College of Ophthalmology at their esteemed London location, and two identical sessions were run on 11 and 12 December 2024. Designed for medical students...
Oral azithromycin for meibomian gland disease
Oral tetracyclines have been the traditional systemic treatment of blepharitis and acne rosacea, through inhibiting bacterial lipase production and reducing fatty acids. However, tetracyclines have a number of adverse side-effects and are required to be taken for a long duration...
Retinal structural features of CMV retinitis
Confocal adaptive optics (AO) technology has enabled cellular level retinal imaging, including imaging of photoreceptors and blood flow. Adaptive optics scanning laser ophthalmoscopy (AOSLO) is a technology that provides high resolution and high contrast retinal images by correcting ocular aberrations....
Phaco-ECP vs. Phaco alone to treat glaucoma
This retrospective review compared combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) to phaco alone in patients with mild to moderate glaucoma. Outcome measures included cumulative full and qualified success survival, postintervention IOP and ocular anti-hypertensive medication reduction. Full success was defined...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
